Splenectomy During Whole Liver Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

141 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Indications for splenectomy during whole liver transplantation remain controversial and splenectomy is often avoided because of common complications. The objective is to evaluate specific complications of these combined procedures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes

NCT06289816

Spleen-Preserving Surgery Echinococcus Granulosus Infection Hydatid Disease +1 more

COMPLETED

Prospective Evaluation of Laparoendoscopic Single Site Versus Laparoscopic Cholecystectomy

NCT00961506

Gallbladder Disease

COMPLETED PHASE2

Roux-en-Y Hepaticojejunostomy for Hepatolithiasis With Sphincter of Oddi Laxity

NCT01459549

Hepatolithiasis Sphincter of Oddi Dysfunction

COMPLETED NA

Safety and Efficacy of Simultaneous or Staged Surgery on Complicated Hepatolithiasis

NCT03098264

Hepatolithiasis

UNKNOWN NA

Identification of Predictive Factors for Failure of Cholangioscopy-assisted Lithotripsy in the Management of Complex Bile Duct Stones: a Retrospective Study

NCT06974695

Bile Duct Stones

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data on patients who underwent splenectomy during liver transplantation were retrospectively analyzed . Participants underwent splenectomy as part of routine medical care. Patients undergoing simultaneous liver transplantation and splenectomy were matched to a non-splenectomy group.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Liver Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Splenectomy

Patients undergoing liver transplantation with simultaneous splenectomy

Splenectomy

Intervention Type PROCEDURE

Splenectomy was performed after hepatectomy, in an extra-hilar manner with manual ligation of splenic vessels.

Liver transplantation

Patients undergoing liver transplantation only

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Splenectomy

Splenectomy was performed after hepatectomy, in an extra-hilar manner with manual ligation of splenic vessels.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Liver transplantation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing liver transplantation between 1994 and 2013

Exclusion Criteria

* Data from living donor patients, split liver transplantation, patients with pre- or post-operative splenectomy in medical history, and patients under 16 years were excluded from analysis

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No